Host: Rabbit
Target Protein: PRRSV-GP5
Specificity: Will detect VR-2332 strain, but not the Lelystad strain
Immunogen Range: 101-200/200
Clonality: Polyclonal
Isotype: IgG
Entrez Gene: 1494885
Swiss Prot: F8TB46
Source: KLH conjugated synthetic peptide derived from PRRSV GP5 (F8TB46)
Purification: Purified by Protein A.
Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
Size: 100ul
Concentration: 1ug/ul
Applications:
WB(1:300-5000)
ELISA(1:500-1000)
Predicted Molecular Weight: 22
Cross Reactive Species: Virus
For research use only. Not intended for diagnostic or therapeutic use.
- Binjawadagi, Basavaraj, et al. "Development of a porcine reproductive and respiratory syndrome virus-like-particle-based vaccine and evaluation of its immunogenicity in pigs." Archives of Virology: 1-11.Read more>>
- Peishan LI. et al. Susceptibility of porcine pulmonary microvascular endothelial cells to porcine reproductive and respiratory syndrome virus. 2020 Aug 21Read more>>
- Hui Ma. et al. Immunization with a recombinant fusion of porcine reproductive and respiratory syndrome virus modified GP5 and ferritin elicits enhanced protective immunity in pigs. Virology. 2021 Jan;552:112Read more>>
- Lei Wang. et al. Heat Shock Protein Member 8 (HSPA8) Is Involved in Porcine Reproductive and Respiratory Syndrome Virus Attachment and Internalization | Microbiology Spectrum. Microbiol Spectr. 2022 FebRead more>>
- Zhao J. et al. The Construction and Immunogenicity Analyses of Recombinant Pseudorabies Virus With NADC30-Like Porcine Reproductive and Respiratory Syndrome Virus-Like Particles Co-expression.. Front Microbiol. 2022 Mar;13:846079-846079Read more>>
- Fu Yang. et al. Lactobacillus rhamnosus GG ameliorates hyperuricemia in a novel model. NPJ BIOFILMS MICROBI. 2024 Mar;10(1):1-22Read more>>
Lane 1: Recombinant PRRSV-GP5 protein, C-His (bs-41026P) probed with PRRSV-GP5 Polyclonal Antibody, Unconjugated (bs-4504R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.